Product Datasheet
|
|
| |
| Product Description |
| |
| Product: |
IgD, Human Myeloma Plasma |
| Catalog Number: |
HU-IGDM |
| Product Page: |
https://www.mol-innov.com/products/IHUIGDMYAP100UG |
| Description: |
IgD was first identified in 1965, and like other immunoglobulins, exists as both secreted and membrane forms. Its level in plasma is low with a mean concentration of 30 ug/ml. IgD is present in large quantities on the surface membrane of a majority of human circulating B lymphocytes. IgD enhances humoral immune responses through its induction of IgD-receptor expression on T lymphocytes. Ref.: Coico RF, Siskind GW, Thorbecke GJ 1988. Immunol. Rev. 105:45. Prepared from myeloma plasma shown to be non reactive for HbsAG, anti-HCV, anti-HBc, and negative for anti-HIV 1 & 2 by FDA approved tests. >95percent pure by SDS-PAGE. |
| Recommended Storage: |
SAMPLE |
| Minimum Shelf Life: |
275.50 |
| Source: |
1.0 mg/ml |
| Molecular Weight: |
Proteins |
| Extinction Coefficient: |
185,000 |
| Antigen: |
-70 C |
| Target: |
Frozen liquid |
| Target Molecular Weight: |
HUMAN IMMUNOGLOBULINS |
| Host: |
712.5 |
| Clonality: |
5 |
| Isotype: |
Human myeloma plasma |
| Clone: |
s |
| Applications: |
Dry ice |
| Cross-reactivity: |
3 years from delivery |
| Concentration: |
290 |
| Volume: |
750 |
| Specific activity: |
SodiumAzide |
| Titer: |
0.01M Tris-HCl; 0.15M NaCl; 0.01M EACA; 0.05% Azide; pH 8.0 |
| Buffer: |
SAMPLE |
| Form: |
0.1 mg |
| Preservative: |
0.1 ml |
| |
| Optimal experimental conditions and working dilutions must be determined by the end user. Sample concentration and volume are for example purposes only and do not necessarily represent the product that will be received. Please contact us for a current lot-specific product datasheet. |
| |
| For in vitro laboratory use only |
| |
Molecular Innovations, Inc. - 46430 Peary Court, Novi, MI 48377, USA
Tel: (888) 557-5055 - Fax: (248) 896-0148 - info@mol-innov.com |